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Objectives: Off periods in Parkinson’s disease (PD) are associated with a worsening 
of non-motor symptoms and acute psychological distress. The relationship between motor 
fluctuations and episodic distress in naturalistic settings remains unclear, particularly the role 
of individual psychological factors. This study aimed to identify those factors through real-
life, real-time assessment using Ecological Momentary Assessment (EMA). 
Methods: Twenty participants (seven female) completed multiple brief prompted 
surveys over a 7-day period assessing current motor and medication state, social situation, 
episodic distress, and cognitive processes (rumination, symptom focus, and worry). Baseline 
depression and anxiety were measured using validated questionnaires, as were positive and 
negative beliefs and attitudes (metacognitions) regarding cognitive processes. The feasibility 
of EMA via smartphones was assessed at the end of the study. 
Results: Four-hundred and ninety-six complete datasets were collected across 
participants. Generalized linear mixed model regression analyses showed that episodic 
distress was predicted by a combination of cognitive processes [F (1, 483) = 41.14, p < .001], 
momentary motor state [F (3, 483) = 10.40, p < .001], time of day [F (1, 23) = 12.42, p = 
.002], and trait negative metacognitions [F (1, 6) = 7.21, p = .037)]. EMA was judged 
acceptable by the majority of participants. 
Conclusions: Time of day, cognitive processes, and negative metacognitions predict 
episodic distress independent of motor state. This indicates potential targets for non-
pharmacological interventions aimed at alleviating episodic distress in patients with motor 




Parkinson’s Disease and Motor Fluctuations 
Parkinson’s disease (PD) is a common neurodegenerative condition, affecting around 
one in 100 people over 70 years of age in the UK (Pringsheim, Jette, Frolkis, & Steeves, 
2014). In addition to motor symptoms, it is associated with a wide range of non-motor 
symptoms (NMS) including depression, anxiety, cognitive impairment, fatigue, sleep 
disturbance, autonomic dysfunction, and pain. NMS can predate motor symptoms, 
contributing an increasing burden with disease progression (Martinez-Martin et al., 2007) and 
having a greater negative impact on health-related quality of life than motor symptoms 
(Martinez-Martin, Rodriguez-Blazquez, Kurtis, & Chaudhuri, 2011). 
Dopamine replacement therapy (DRT) is linked to a range of complications with 
long-term use including motor fluctuations, ranging from akinetic-rigid hypodopaminergic 
‘off’ periods/states, to phases of relatively good motor control (‘on’ periods/states) or 
hyperdopaminergic dyskinetic states (Bjornestad et al., 2016; Kostić, Marinković, Svetel, 
Stefanova, & Przedborski, 2002; Schrag & Quinn, 2000). Off periods are attributed to 
‘wearing off’ (related to the time elapsed since the previous DRT dose), a ‘delayed on’ (when 
a DRT dose-effect occurs later than expected), or when a DRT dose has no effect (Lyons & 
Pahwa, 2011). In addition to increased motor symptom severity, off periods are also 
associated with an acute emergence or worsening of a range of NMS including autonomic 
symptoms, fatigue, pain, limb paresthesia, cognitive/concentration difficulties, low mood, 
and anxiety (Rizos et al., 2014; Storch et al., 2013). 
Emotion in Parkinson’s Disease 
Anxiety and depression are frequently co-morbid in PD, with their etiology and 
maintenance likely due to underlying disease-specific pathophysiology and psychosocial 
factors common to other chronic health conditions (Schrag, Jahanshahi, & Quinn, 2001; Tang 
& Strafella, 2012; Veazey, Aki, Cook, Lai, & Kunik, 2005). Prevalence estimates of mood 
  
disorders in PD are high: e.g., between 25% and 43% for anxiety disorders (Dissanayaka et 
al., 2010; Pontone et al., 2009), 17% for major depressive disorder, 22% for minor 
depression, 13% for dysthymia, and 35% for clinically significant sub-threshold depressive 
symptoms (Reijnders, Ehrt, Weber, Aarsland, & Leentjens, 2008). Some PD patients may 
suffer from a combination of anxiety and depressive symptoms that do not meet diagnostic 
criteria for a psychiatric disorder but have a significant impact on quality of life (Reiff et al., 
2011; Santangelo et al., 2014; Schapira, Chaudhuri, & Jenner, 2017). While anxiety and 
depression refer to formal psychiatric disorders and their subsyndromal forms, the broader 
construct of ‘psychological distress’ is commonly used to describe a negative mixed 
emotional state and its physical concomitants. Distress may occur in a wide range of 
situations in the context of physical or psychological discomfort or threat often experienced 
by people living with chronic health conditions. 
Greater levels of depression and particularly anxiety have been reported in patients 
who experience motor fluctuations compared to those who do not (e.g., Burn et al., 2012; 
Pontone et al., 2009). These mood states may span motor states, though there is compelling 
evidence of acutely elevated distress during off periods for many patients (Brown, Marsden, 
Quinn, & Wyke, 1984; Cantello, Gilli, Riccio, & Bergamasco, 1986; Leentjens et al., 2012; 
Menza, Sage, Marshall, Cody, & Duvoisin, 1990; Nissenbaum et al., 1987; Racette et al., 
2002). However, these studies did not gather longitudinal and/or naturalistic data, tempering 
the strength of conclusions about the temporal relationship between mood and motor state. 
Furthermore, episodic distress may have a direct hypodopaminergic component (Martinez-
Fernandez, Schmitt, Martinez-Martin, & Krack, 2016), as well as reflecting an emotional 
response to worsening motor and NMS. 
However, acute episodic distress is not an inevitable feature of off periods. For 
example, it may be moderated by psychosocial factors, such as the nature of the interpersonal 
  
relationships of people living with PD or exacerbated by a sense of embarrassment (Backer, 
2000; Frazier, 2000). Specific cognitive processes may also play a key role in distress: e.g., a 
tendency to ruminate and engage in symptom focusing (Julien, Rimes, & Brown, 2016) have 
been incorporated into a recent cognitive model of anxiety and depression in PD (Egan, 
Laidlaw, & Starkstein, 2015). Rumination refers to a cognitive process characterized by 
repetitive thinking about abstract questions (e.g., “Why is this happening to me?”) and 
symptom focusing to attentional focus on PD symptoms whether momentarily present or not. 
The Self-Regulatory Executive Function (S-REF) model asserts that cognitive 
processes (such as rumination, symptom focus, and worry) are components of a Cognitive 
Attentional Syndrome (CAS), causing and maintaining psychological distress, and are fueled 
by the beliefs held about them, referred to as ‘metacognitions’ (Wells & Matthews, 1994, 
1996). These beliefs can be conceptualized as ‘thoughts-about-thoughts’ that outline ‘general 
plans for processing and coping’ (Wells, 2002, 2009). Metacognitions are often categorized 
as positive (e.g., “If I focus on my symptoms, I can better control them.”) or negative (e.g., 
“Once I focus on my symptoms, I find it impossible to pay attention to anything else.”). In 
PD, metacognitions have been implicated in both general and episodic distress (Allott, Wells, 
Morrison, & Walker, 2005; Brown & Fernie, 2015; Fernie, Spada, Ray Chaudhuri, 
Klingelhoefer, & Brown, 2015). 
Study Aims 
Clinically, when effective control of motor fluctuations is limited, interventions are 
needed to reduce their psychological burden. Identifying psychosocial predictors of episodic 
distress, independent of motor state, may reveal novel targets for non-pharmacological 
interventions. The present study aimed to extend previous research, testing whether 
momentary motor state, the CAS, and metacognitions (Brown & Fernie, 2015; Fernie, Spada, 
et al., 2015) contribute to episodic distress (experienced by people with PD who have 
  
developed motor fluctuations) using data gathered in naturalistic settings. The current study 
used Ecological Momentary Assessment (EMA), which has been successfully used 
previously in PD (Broen et al., 2016; van der Velden, Mulders, Drukker, Kuijf, & Leentjens, 
in press). EMA possesses several advantages relevant to the current study’s aims. It is less 
vulnerable to retrospective recall biases than studies that employ self-report measures with 
cross-sectional designs. EMA gathers real-time, longitudinal quantitative data in a naturalistic 
setting. 
The current study had two central objectives: examining the acceptability and 
feasibility of using EMA, and identifying factors associated with episodic distress (including 
those derived from the S-REF model), in a sample of people living with PD who have 
developed motor fluctuations. Capturing momentary changes in distress and motor state was 
vital to testing the current study’s two hypotheses that operationalized the second objective: 
i.e., (1) there would be a reliable relationship between motor state and episodic distress, and 
(2) cognitive processes and metacognitions would significantly predict episodic distress when 
controlling for motor state. 
Methods 
Participants 
Twenty participants (seven females; mean age = 60.8 years; range 48-79; SD = 9.3) 
were recruited from the Movement Disorders Service at a London Hospital (n = 18) and 
through web-adverts published by a patient advisory group (n = 2; Parkinson’s UK). 
Eligibility criteria required participants: (1) had a clinical diagnosis of idiopathic PD, (2) 
were taking DRT, (3) self-reported experiencing off periods for at least 25% of their day 
(however, participants were not required to report elevated levels of episodic or general 
distress), (4) adequately comprehended the English language, (5) were able to use a touch 
screen on a smartphone, (6) did not have clinical evidence of dementia, and (7) were able to 
  
provide informed consent. The Movement Disorders Service identified 19 eligible and 
interested individuals, all of whom provided consent to participate in the study. However, one 
individual later decided not to participate before contributing any data, after reflecting that 
adhering to the EMA schedule would be too demanding. The two participants recruited 
following Parkinson’s UK were the first two individuals who contacted the research team. 
The study received ethical approval from the Dulwich Research Ethics Committee 
(14/LO/0714). 
Measures and Procedure 
Following consent, participants provided demographic and clinical information, 
including date of PD diagnosis, typical pattern of motor fluctuations, and medication 
regimen. Participants also completed three self-report measures assessing trait 
metacognitions and affect over the previous 2 or 4 weeks. The 17-item Metacognitions about 
Symptom Control Scale (MaSCS; Fernie, Maher-Edwards, Murphy, Nikcevic, & Spada, 
2015) assessed both positive and negative metacognitions (PM and NM) about rumination 
and worry about symptoms and symptom focus. An earlier study tentatively reported a 
relationship between PM and NM with anxiety and depression in a sample of people with PD 
and distressing off periods (Fernie, Spada, et al., 2015). Higher scores on the MaSCS indicate 
stronger endorsement of PM and NM. Anxiety over the preceding 4 weeks was assessed 
using the 12-item Parkinson’s Anxiety Scale (PAS; Leentjens et al., 2014), consisting of 
three subscales (persistent, episodic, and avoidance anxiety), and depressive symptoms over 
the past 2 weeks using the nine-item Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, 
& Williams, 2001). The PAS and PHQ-9 were used to characterize the sample but not in the 
subsequent modelling. 
After completing the self-report measures, participants began a 7-day EMA data 
collection period. An EMA software application (‘App’) was built on the MovisensXS 
  
platform (gathering encrypted data) for Android operating system (GmbH, 2015) and 
deployed on ‘Google Nexus 5’ smartphones (on which all telephony and data services had 
been disabled), provided by the research team for the study period. The App’s design was 
informed by feedback from Parkinson’s UK. It was programmed to produce four random 
auditory alerts per day, scheduled between 8am and 8pm (stratified into four, 3-hour 
windows). Following an alert, participants could choose to complete (or postpone, or dismiss, 
completion of) a brief survey. Also, participants could self-initiate a survey at any time. The 
context data gathered by EMA was structured and momentary time sampled. 
Each survey consisted of seven items asking about their momentary motor state 
(‘Motor’, including on and off periods and transitional states: i.e., on-wearing-off and off-
coming-on), the psychosocial context (‘Company’), the interval between the survey time and 
the last DRT dose (‘Medication’), level of episodic distress (‘Distress’), and the extent which 
a participant was engaging in certain cognitive processes (see Supplementary Material 1). 
Episodic distress and cognitive process engagement was assessed using an ordinal, five-point 
response format. The hour of the day each individual survey was completed defined the 
variable ‘Time’. How a survey was initiated (either participant-initiated or in response to a 
random alert) was used to create a dichotomous variable labelled ‘Trigger’. 
Before beginning the EMA data collection period, participants were taught how to use 
the smartphone and the App and provided with an instruction manual (paper copy) for 
reference. Also, participant could use the App to send messages to the research team, or 
could contact them by telephone or email, should they have had any questions or concerns 
about using the App (or about the study in general). Following the EMA data collection 
period, participants were debriefed and completed a questionnaire addressing the usability of 
the App. 
Data Processing and Statistical Analysis Methods 
  
All analyses were conducted using version 24 of SPSS (International Business 
Machines Corporation, 2017). Means, SD, ranges, and (following normality tests) non-
parametric correlation analyses were calculated using all baseline self-report measures. 
Counts, medians, IQRs, ranges, and percentages were used to describe the characteristics of 
the EMA data in terms of momentary motor state and how completed surveys were triggered. 
Detailed analysis of EMA data to test the study’s hypotheses was achieved with 
generalized linear mixed regression modeling (GLMM). GLMMs allow both fixed and 
random effects to be specified as predictors for non-normally distributed and non-continuous 
dependent variables. Fixed effects are variables generalizable to a wider population while 
random effects are specific to the sample. Random effects model variation between 
participants, contributing to the control of individual differences. EMA produces 
longitudinal, real-time data. When analyzing data with these characteristics it is important 
that time is modelled. GLMMs can control for time by specifying it as a repeated measures 
effect, fixed effect, and/or as a random effect (i.e., a random slope describing relationships 
between time and the outcome variable for each participant). 
The GLMMs built for the current study controlled for time by specifying it as a fixed 
effect (which modelled the relationship between the hour of day and episodic distress for the 
whole sample) and a random slope (modelling variation in how episodic distress changed 
over the course of a day for each participant). The GLMMs reported in the current study all 
used episodic distress as the dependent variable with multinomial distributions and a Probit 
link function (modelling the relationship between the independent variable and the dependent 
variable). The models employed robust estimation to ‘handle violations of model 
assumptions’ and Satterthwaite approximation. Random effects were modelled using a 
variance components covariance matrix. 
  
The current study reports two GLMMS. The first model focused on the relationship 
between episodic distress with momentary motor state while the second the relationship 
between motor state and momentary cognitive process activation and metacognitions. The 
first model controlled for Time, Company, Medication, and Trigger. The second model was 
built from the first, controlling for significant predictors that had been found while excluding 
those nonsignificant. This exclusion strategy was employed to optimize the number of 
parameters needed to estimate the model, enhancing statistical power. 
Results 
Participant Characteristics and Baseline Self-Report Measures  
All 20 participants had received a clinical diagnosis of PD and were taking DRT. The 
mean duration since the participants’ PD diagnosis was 7.6 years (range 1 to 20 years; SD = 
5.1). All participants self-reported experiencing motor fluctuations and spending a quarter of 
their days in an off state. Nineteen participants self-reported as British. All but three 
participants reported that English was their first language. All participants had attended 
formal education up until at least the age of 16 years, with four educated to university degree-
level. 
Table 1 shows the means, SD, and intercorrelations between the self-report measures 
assessed at baseline. NM (but not PM) positively and significantly correlated with total PAS 
and PHQ-9 scores. Twelve participants had significant anxiety based on the total PAS score 
(cut-off 13/14), with six showing significant persistent anxiety (cut-off 9/10), three 
significant episodic anxiety (cut-off 5/6), and nine significant avoidance anxiety (cut-off 4/5). 
On the PHQ-9, nine showed evidence of no, minimal, or mild depression (score < 10), six 
moderate depression (score 10-14), and five moderately severe depression (score 15-27). 
Characteristics of Ecological Momentary Assessment Data 
  
A total of 560 random alerts were produced by the smartphone App over the 
combined study periods for all participants, of which 50.2% generated completed EMA 
surveys. Four-hundred and ninety-eight completed surveys were generated, of which 43.6% 
were participant-initiated surveys. Table 2 shows the counts of completed surveys, stratified 
by Trigger and Motor. Five (25.0%) participants did not complete a survey during an off 
period, four (20.0%) when off-coming-on, and two (10.0%) when on-wearing-off. All 
participants completed surveys when on. Thirteen (65.0%) participants completed surveys in 
response to 50% or more of the random alerts, seven (35.0%) to 60% or more, and five 
(25.0%) to 70% or more. Of the 279 (49.8%) of the random alerts that were not responded to, 
33 (11.8%) were actively dismissed, 136 (48.7%) ignored, six (2.2%) incomplete, and for 104 
(37.3%) no data was recorded. The latter likely indicated the smartphone was switched off or 
out of battery. The mean recorded duration taken to complete a survey was 68.5 seconds 
(range 13-606 seconds; SD = 48.6). 
Relationships Between Momentary Distress and Motor State 
 Figure 1 is a mean error bar graph that plots Motor against person-mean centered 
episodic distress. Episodic distress was person-mean centered to calibrate participants’ 
ratings relative to the individual. A visual inspection of Figure 1 indicates participants 
experienced greater levels of episodic distress when they were off and off-coming-on 
compared to when they were on and on-wearing-off. Greater levels of episodic distress 
during off periods compared to on periods aligns with the findings of earlier studies. The 
apparent difference in levels of episodic distress between transitional motor states (i.e., off-
coming-on versus on-wearing-off) is a new finding. 
 The first GLMM (Model 1) comprised of five fixed effects (Motor, Company, 
Medication, Trigger, and Time) and two random effects (comprising of an intercept and a 
slope). The random intercept was defined using an index variable that identified each 
  
participant (ID) and modelled variation in episodic distress between them. The random slope 
represented the relationship between ID and Time for each participant separately. Overall, 
Motor and Time were the only significant predictor fixed effects of episodic distress (see 
Table 3) and this model correctly classified 62.2% of responses. The parameter estimates for 
the four nominal motor states show that on periods and on-wearing-off states were associated 
with significantly less episodic distress than off periods (see Supplementary Material 2). 
However, there was no significant difference in episodic distress when off and off-coming-
on, aligning with a visual inspection of Figure 1. 
The significant Time fixed effect indicated that (overall) participants were more 
distressed as each day progressed. The parameter estimates for the random slope (see 
Supplementary Material 2) suggested that this change in episodic distress over the course of a 
day did not significantly vary between participants. However, the parameter estimates for the 
random intercept found significant variation in the spread of episodic distress between 
participants, ID: Estimate = 0.927, SE = 0.423, Z = 2.192, p = .028, 95% CI [0.379, 2.266]. 
This suggested the pattern of increasing episodic distress as a day progressed was 
generalizable to the sample and did not differ between individuals, despite variation in the 
spread of episodic distress between participants. 
Relationship Between Episodic Distress, Momentary Cognitive Attentional Syndrome 
Activation, And Metacognitions 
 According to the S-REF model, rumination, symptom focus, and worry are all 
components of a CAS. The raw data of this study generated three separate variables to 
represent these cognitive processes. If these three variables represented a single, latent-
variable, a composite CAS score could be calculated. Specifying a single CAS variable, 
rather than three variables representing separate cognitive processes, would reduce the 
number of parameters needed to be estimated for the GLMM. To justify the creation of a 
  
single CAS variable, a principle components analysis of the entire dataset was conducted. 
This revealed that the three survey items referring cognitive processes loaded heavily on a 
single factor (factor loadings: rumination = 0.91; symptom focus = 0.92; and worry = 0.88). 
This factor had an Eigen value of 2.44 that explained 81.4% of the variance. This latent 
variable was labelled CAS and calculated by summing rumination, symptom focus, and 
worry responses. The CAS variable was person-mean centered because (1) it was time-
dependent and (2) this would represent within-participant differences (i.e., how individuals 
rate their engagement in momentary rumination, symptom focus, and worry on a five-point, 
Likert-type scale was assumed to be personally, rather than generally, calibrated). PM and 
NM scores were grand-mean centered to create variables representing between-participant 
differences. 
 Figure 2 displays four spaghetti plots of CAS against person-mean centered episodic 
distress paneled by momentary motor state. The thickest line in each of the four plots 
represents the relationship between individually-relative, momentary CAS activation and 
episodic distress across all participants. A visual inspection of these spaghetti plots suggests a 
positive relationship between momentary CAS activation and episodic distress that appears 
more pronounced during off and on periods than transitional motor states. However, the slope 
in the on-wearing-off panel appears steeper than that in the off-coming-on panel. This 
suggests that CAS activation influences episodic distress more when participants were 
wearing off than when coming on. 
 The significant fixed effects from Model 1 (Motor and Time) were specified in the 
second GLMM (Model 2) along with three new fixed effects (CAS, PM, and NM). The same 
random effects specified in Model 1 were used in this model. Model 2 found that the overall 
effect of Motor, Time, CAS, and NM (but not PM) were significant predictors of Distress 
(see Table 3). Higher Distress was associated with higher CAS and baseline NM scores. The 
  
addition of CAS, PM, and NM altered the relationships between the transitional motor states 
and off periods compared to Model 1: i.e., there were no longer significant differences 
between them (see Supplementary Material 2). Like Model 1, the random intercept but not 
the random slope was a significant predictor of episodic distress (see Supplementary Material 
2), ID: Estimate = 1.344, SE = 0.521, Z = 2.560, p = .010, 95% CI [0.620, 2.869]. Model 2 
correctly classified 70.0% of responses. 
Feasibility of Ecological Momentary Assessment 
The usability survey indicated only one participant reported that using the App during 
both on and off periods was ‘quite hard’, the rest said it was either ‘very easy’ (on periods = 
15; off periods = 12) or ‘quite easy’ (on periods = 4; off periods = 7). Of those who did not 
find it ‘very easy’ to use the App, the most common feedback was a request to increase the 
font size of survey items. The majority of participants (n = 11) described feeling ‘nothing’ 
when a random alert sounded and while six said they felt ‘pleased or interested’. However, 
three participants reported they were ‘occasionally irritated’ (n = 2) or ‘often irritated’ (n = 
1). Most participants (n = 12) stated the number of random alerts per day was ‘about right’ 
and six said they would have been happy with more (though two reported there were too 
many). Just over half the participants (n = 11) said the 1-week length of the study was ‘about 
right’. Seven stated they would have been happy to take part in the study for 2 to 3 weeks, but 
two said the 1-week duration of the current study was ‘too long’. Nineteen participants said 
the ability to dismiss or postpone random alerts was either ‘very helpful’ (n = 11) or 
‘somewhat helpful’ (n = 8), while one stated it was ‘neither helpful nor unhelpful’. All 
participants stated they would ‘definitely’ or ‘possibly’ have liked some feedback on their 
App responses at the end of each day. The most common suggestion for feedback was an 
illustration of their daily mood changes. 
Discussion 
  
This study generated longitudinal data in a naturalistic setting, employing EMA 
delivered via touchscreen smartphones in a sample of people living with PD, and had two 
central objectives. It aimed to assess the acceptability and feasibility of using smartphone 
devices to collect EMA data in a sample of people living with PD who had developed motor 
fluctuations and to identify predictors of episodic distress. The latter was operationalized and 
tested by two hypotheses: (1) there would be a relationship between momentary motor state 
and episodic distress, and (2) cognitive processes and metacognitions would significantly 
predict episodic distress when controlling for motor state. 
 EMA was judged acceptable to nearly all the participants and seven said they would 
be prepared to participate in a study of a longer duration. However, one individual was 
initially enrolled in the study but later decided to not participate after reflecting on the EMA 
study demands (this individual did not contribute data to the current study). None of the 
participants reported the App was substantially more difficult to use across motor states (the 
participant who reported that it was ‘quite hard’ to use the App gave the same rating for both 
on and off periods). This suggests that the usability of the App was independent from motor 
state, and difficulty-of-use was the result of individual differences (e.g., some individuals 
may not be comfortable using touchscreen devices). The usability of EMA could be 
improved by presenting items in a larger font. Combined with the evidence on data 
completeness, the present study support a previous research (Broen et al., 2016) on the 
feasibility of using EMA with a mobile device in PD. 
Episodic distress seemed to worsen as the day progressed in this sample in contrast to 
the diurnal increase in positive affect found in depressed individuals in the general population 
(Peeters, Berkhof, Delespaul, Rottenberg, & Nicolson, 2006). It is possible that the EMA 
methodology itself contributed to this finding: e.g., perhaps participants became increasingly 
distressed as the day progressed as they waited for an alert to complete yet another survey. 
  
Another possible explanation is that participants were more distressed as the day progressed 
because of increasing fatigue and/or a cumulative effect of dealing with symptoms.  
The current study also investigated the effect of the time elapsed since the most recent 
DRT dose and episodic distress. Contrary to Maricle et al.’s (1995), the current study did not 
find a significant relationship between these variables. Additionally, the current study did not 
find a significant relationship between episodic distress and psychosocial context: i.e., the 
presence or absence of other people was not associated with episodic distress when 
controlling for momentary motor state. 
Overall, the results provide further evidence for a relationship between episodic 
distress and momentary motor state (hypothesis 1): i.e., episodic distress is worse during off 
periods compared to on periods. However, a counterintuitive pattern was observed for the 
transitional motor states: i.e., greater episodic distress was reported when participants were 
off-coming-on compared to when they were on-wearing-off (see Figure 1). It might be 
assumed that wearing off would be associated with greater episodic distress because this 
signifies the onset of worsening motor symptoms. Possibly, when individuals are waiting to 
come on, they might engage in increased symptom focus (part of the CAS, which this study 
found was associated with episodic distress) to monitor for any improvement because of 
concerns about delayed on and no effect DRT dose-responses. Whereas, once wearing off has 
been identified, the focus is more on practical coping strategies (e.g., taking medication). 
Some support for this interpretation is offered by the spaghetti plots (Figure 2), which 
suggests that CAS activation has little relationship to episodic distress when on-wearing-off 
compared to off-coming-on. While the pattern relative to on and off periods may reflect 
interactions between motor and non-motor factors, the results may also reflect limited power 
to separate out subtle differences in motor state and/or reliability of self-report. This study 
also offers partial support for the second hypothesis: i.e., episodic distress is greater at times 
  
when a person is engaging in the CAS and generally higher in those individuals holding 
negative metacognitive beliefs about symptom control (independently of motor state). The 
significance of the CAS and negative metacognitions in predicting episodic distress align 
with an earlier model suggested by Brown and Fernie’s (2015), although their hypothesized 
role of positive metacognitions was not supported by the present data. 
These present results suggest novel potential targets for a non-pharmacological 
intervention aiming to reduce motor fluctuation-related distress in PD. Metacognitive 
Therapy (MCT; Wells, 2009), based on the S-REF model, is relatively new psychological 
approach. Unlike CBT, which directly aims to modify the content of maladaptive thoughts 
and beliefs, MCT aims to weaken perseverative CAS configurations. In light of the current 
study’s findings, which suggest that CAS configurations play an importantly role in episodic 
distress in PD, future research should investigate the effect of MCT interventions in this 
population. A variety of relatively simple tools and techniques are used in MCT that can be 
practiced by the individual in their own time such as Attention Training Technique, which 
aims to improve attentional control and disrupt perseverative CAS configurations (Wells, 
1990). Additionally, MCT interventions could be used to modify NM found by the current 
study to be associated with episodic distress. 
Limitations 
This study is subject to several limitations. Firstly, the study’s sample size was 
relatively small for an EMA study, although not unusually so for one conducted in a clinical 
population (see aan het Rot, Hogenelst, & Schoevers, 2012 for a review). Secondly, only 
50.2% of random alerts in this study resulted in a complete EMA survey, whereas Broen et al 
(2016) reported a substantially higher rate of compliance (84%, range 76% to 96%; n = 5) 
with a more demanding schedule (i.e., ten alerts per day). In the current study, surveys could 
be dismissed and self-triggered - an option incorporated following consultation with an 
  
expert patient group. Although, the incorporation of self-triggered survey data raises concerns 
about response biases (e.g., participants might systematically initiate and complete surveys 
when feeling less distressed), the results did not support this contention (i.e., how surveys 
were triggered was not significantly associated with episodic distress). Thirdly, five 
participants did not complete any EMA surveys when they were in an off state, restricting the 
range of data they contributed to the GLMMs. Fourthly, assessment of momentary motor 
state was reliant on a self-report survey item. Future studies could consider using 
accelerometer data from smartphones and/or wearable devices to triangulate self-reports of 
momentary motor state. Fifthly, the design of the current study did not control for the impact 
that off periods have on cognitive functioning (see Goldman et al., 2018), which may 
have amplified measurement error in survey responses (assessing levels of episodic distress 
and CAS activation) in such motor states. Future studies might consider evaluating 
participants’ cognitive functioning with neuropsychological testing during on and off 
states before beginning EMA study. These measurements could help to build GLMMs to 
control for variation in EMA responses due to different levels of cognitive impairment in on 
and off states. Sixthly, the sample was not specifically selected for the presence of motor 
fluctuation-related distress This was intended to assess a range of motor fluctuation-related 
psychological change. It is possible that different patterns of results may emerge in a high 
distress sample. However, although the final models may change, it is judged likely that 
similar factors would be identified. Finally, PAS and PHQ-9 scores were controlled for in the 
GLMMs. However, finding either of these variables to be episodic distress would not have 
revealed novel targets for psychological intervention. 
Conclusions 
Despite these limitations, the current study provides evidence for the expected 
relationship between motor state and episodic distress using longitudinal, naturalistic real-
  
time data. It also indicates a significant contribution of non-affective psychological factors in 
determining the severity of episodic distress in people living with PD who experience motor 
fluctuations. The results suggest the potential clinical value of applying techniques from 
MCT that aim to reduce perseverative CAS configurations. This study also supports Broen et 
al.’s (2016) conclusion that EMA is a feasible tool for PD research. 
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Figure 1: Mean Error Bar Graphs of Episodic Distress by Momentary Motor State 
  
Notes. Error Bars = 95% Confidence Intervals; data-points = 498; n = 20.
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Figure 2: Spaghetti Plots of Momentary CAS Activation by Episodic Distress Panelled by Motor State 
 
Notes. Thin lines = lines of best for each participant; thick lines = lines of best fit combining data from all participants; data-points = 498; n = 20. 
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Table 1: Means, Standard Deviations, Ranges, and Correlations of Self-Report Measures 
Measure Mean SD Range 1 2 3 4 5 6 7 
1. MaSCS – PM 20.78 5.79 9-29  .02 .37 -.18 -.09 -.02 -.15 
2. MaSCS – NN 18.05 5.34 8-32   .38 .40 .40 .49* .54* 
3. PAS – Avoidance 4.15 2.64 0-9    .37 .52* .70** .50* 
4. PAS – Episodic 3.55 3.68 0-16     .65** .75** .52* 
5. PAS – Persistent 9.05 5.40 2-20      .93** .51* 
6. PAS – Total 16.75 9.88 2-42       .67** 
7. PHQ-9 11.15 5.10 2-22        
Note. MaSCS = Metacognitions about Symptom Control Scale (PM = positive metacognitions; NM = negative metacognitions); PAS = 
Parkinson’s Anxiety Scale; PHQ-9 = Patient Health Questionnaire - 9; * p < 0.05; ** p < 0.01; n = 20.
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Table 2: Trigger and Momentary Motor State of Completed Surveys 
 Random alerts Participant-initiated Total 








Count (% of 
completed surveys) 
Median (IQR) and 
range 
Completed surveys       
 Over study period 281 15.5 (8.5); 1 to 24 217 7 (11); 1 to 28 498 26 (12.25); 8 to 38 
 While off 43 (51.8%) 1.5 (4); 0 to 8 40 (48.2%) 1 (3); 0 to 7 83 (16.7%) 3 (5.5); 0 to 15 
 While off-coming-on 33 (54.1%) 1 (2.5); 0 to 7 28 (45.9%) 1 (2); 0 to 6 61 (12.2%) 3 (2.5); 0 to 8 
 While on 153 (57.1%) 7 (6.5); 0 to 16 115 (42.9%) 3 (4.5); 0 to 20 268 (53.8%) 12 (9); 4 to 32 
 While on-wearing-off 52 (60.5%) 3 (4.25); 0 to 6 34 (39.5%) 1 (2); 0 to 10 86 (12.2%) 3 (2.5); 0 to 8 
Note. Study period = 7 days; n = 20. 
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Table 3: Fixed Effects for Two Generalised Linear Mixed Models with Episodic Distress as The Dependent Variable 
Fixed effect Model 1: F (df1, df2) Model 2: F (df1, df2) 
Corrected model 35.47 (9, 489) *** 23.68 (7, 483) * 
Motor 14.53 (3, 489) *** 10.40 (3, 483) *** 
Time 8.68 (1, 35) ** 12.42 (1, 23) ** 
Company 1.40 (3, 489) - 
Medication 1.14 (1, 489) - 
Trigger 0.09 (1, 489) - 
CAS - 41.14 (1, 483) *** 
PM - 0.50 (1, 10) 
NM - 7.21 (1, 6) * 
 Note. Motor = motor state; Time = person-mean centred hour of day; Company = psychosocial context; Medication = interval between present 
moment and last dopamine replacement therapy; Trigger = how a survey initiated; CAS = person-mean centred Cognitive Attentional 
Syndrome; PM = positive metacognitions; NM = negative metacognitions; * p < 0.05; ** p < 0.01; *** p < 0.001; n = 20. 
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Supplementary Material 1: Ecological Momentary Assessment Survey Items 
Construct (variable 
name) 
Item Responses Recoding (data-type; levels) 
Motor state (Motor) “At the moment I am…” 
(0) “on”; (1) “on-coming-off”; 
(2) “off-wearing-on”; (3) “off” * 
No recoding (categorical; four-level) 
Psychosocial context 
(Company) 
“Who is with you?” 
(0) “no-one”; (1) “people I don’t 
know”; (2) “friends or family”; 
(3) “other people I know” * 
No recoding (categorical; four-level) 
Time elapsed since last 
DRT dose (Medication) 
“I took my last tablet…” 
(0) “more than an hour ago”; (1) 
“31-60 minutes ago”; (2) “less 
than half an hour ago” 
(0) more than an hour ago; (1) one 
hour or less* (categorical; two-
level) 
Rumination (CAS) 
“Were you dwelling on your thoughts, 
feelings, and/or physical symptoms?” 
Five-point Likert-type scale; (0) 
“not at all” to (4) “extremely”* 
Component variables summed to 
create a composite CAS score 
(ordinal; five-level) 
Symptom focus (CAS) 
“Were you focusing on your 
symptoms?” 
Worry (CAS) “Were you worrying about things?” 
Episodic distress 
(Distress) 
“Were you feeling distressed?” No recoding (ordinal; five-level) 
Notes. CAS = Cognitive Attentional Syndrome; DRT= dopamine replacement therapy. * = reference category.
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Supplementary Material 2: Parameter Estimates for Two Generalised Linear Mixed Models with Episodic Distress as The Dependent Variable 
Fixed effects Estimate SE t p 
CI95 
Lower Upper 
Model 1       
Motor 
On period -1.037 .2059 -5.034 .000 -1.441 -.632 
On-wearing-off state -.456 .1699 -2.682 .008 -.789 -.122 
Off-coming-on state .061 .2190 .277 .782 -.370 .491 
Off period [RC] 0 . . . . . 
Time  .051 .0175 2.946 .006 .016 .087 
Company 
No-one .041 .1738 .236 .813 -.300 .383 
People I don’t know 1.018 .5638 1.805 .072 -.090 2.126 
Friends and family .240 .1978 1.215 .225 -.148 .629 
Other people I know [RC] 0 . . . . . 
Medication 
More than an hour ago -.143 .1343 -1.065 .287 -.407 .121 
1 hour ago, or less [RC] 0 . . . . . 
Trigger 
Random alert .039 .1293 .305 .760 -.215 .293 
Participant initiated [RC] 0 . . . . . 
Model 2       
Motor 
On period -.474 .1964 -2.413 .016 -.860 -.088 
On-wearing-off state -.129 .2054 -.631 .529 -.533 .274 
Off-coming-on state .277 .1815 1.527 .127 -.079 .634 
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Off period [RC] 0 . . . . . 
Time  .053 .0150 3.524 .002 .022 .084 
CAS .311 .0485 6.414 .000 .216 .407 
Positive Metacognitions -.030 .0429 -.699 .501 -.126 .066 
Negative Metacognitions .110 .0410 2.685 .037 .009 .211 
 Random effects Estimate SE Wald Z p 
CI95 
Lower Upper 
Model 1       
Intercept (ID)  .927 .423 2.192 .028 .379 2.266 
Slope (ID by Time)  .002 .001 1.227 .220 .000 .008 
Model 2       
Intercept (ID) 
 
1.334 .521 2.560 .010 .620 2.869 
Slope (ID by Time) 
 6.325 × 10)* .001 .068 .946 2.170× 10),- 1.843× 100 
 Note. RC = reference category; Motor = motor state; Time = person-mean centred hour of day; Company = psychosocial context; Medication = 
interval between present moment and last dopamine replacement therapy; Trigger = how a survey initiated; CAS = person-mean centred 
Cognitive Attentional Syndrome; ID = participant identifier; bold type indicates variable or variable level with a significant p-value; n = 20. 
 
 
